Japanese scientists applied a genetic engineering technique, called as ‘genome editing technology’ for breeding hens that can lay eggs with the contents of interferon beta, which is a cancer-fighting drug. The drug is a pharmaceutical agent as well as a helpful protein to treat malignant skin cancer, multiple sclerosis and hepatitis. The consumption of these eggs may reduce significantly the cost of treatment for cancer treatment.
The researchers’ team of this latest invention belonged to the National Institute for the Advanced Industrial Science and Technology (AIST) at Kansai in Japan. The team informed that if it is injected into cancer victims for three times a week, it will prevent the cancer cells from being multiplied and boosting T cells at the same time to fight against tumors.
But this highly efficient remedy is too expensive, as the current production of these eggs with just few micrograms of the drug cost between a range of $250 and $900.
The new technology is expected to be practically using as early as the following year to widespread this cancer-fighting drug, halving initially into the conventional production cost. There is a hope that the cost eventually drop eventually to below or nearly 10 per cent.
A Chairman of the Cleveland Clinic Taussig Cancer Center, Brian J. Bolwell stated while explaining that, “The monthly cost for new cancer drugs, especially immunologically or genomically based therapies, has increased 77-fold since 1975 [in the U.S.]. A single drug can now cost over $300,000 per year. Cancer drugs are not a luxury item, like an expensive car, that people can choose to buy or not to buy…. When prices come down, mortality rates will surely follow.”